326
edits
Changes
no edit summary
| add = olanzapine
| info =
* Valproic acid is principally metabolized by CYP2C9, CYP2C19, CYP2A6 and UDP-glucuronosyltransferases. Valproic acid is an inhibitor of the enzymes CYP2C9, epoxide-hydroxylase and UDP-glucuronosyltransferases. * Olanzapine is principally metabolized by CYP1A2 and CYP2D6.
| start =
* Start olanzapine according to the general dosing advice. Monitoring of the liver function every 3 to 4 months during the first year of treatment with either olanzapine or valproic acid is recommended.<ref name="drugscom">{{DRUGSCOMDrugscominteract|olanzapine-with-valproic-acid-1744-0-2286-0|olanzapine|valproic acid}}</ref>
| cave =
* Concurrent use of olanzapine and valproic acid may potentiate the risk of hepatotoxicity. <ref name="drugscom">{{DRUGSCOM|olanzapine}}</ref>
}}
